Trials / Completed
CompletedNCT01057160
Rizatriptan 10 MG RPD in the Treatment of Acute Migraine
A Study of the Efficacy and Safety of Rizatriptan 10 mg RPD in the Treatment of Acute Migraine in Patients With Non Satisfactory Response to Previous Pharmacologic Treatment
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 195 (actual)
- Sponsor
- Universität Duisburg-Essen · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicentre, open label, prospective, randomized, two-attack study with active comparator in patients reporting inadequate response to analgesics and/or triptans to examine the efficacy of Rizatriptan 10 mg RPD in this group of patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rizatriptan | use of rizatriptan 10 mg for one migraine attack, in comparison to previously used analgetic |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2010-06-01
- Completion
- 2010-06-01
- First posted
- 2010-01-27
- Last updated
- 2013-01-28
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01057160. Inclusion in this directory is not an endorsement.